Multifunctional imaging nanoprobes

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 2, Issue 2, 2010, Pages 138-150

  Jarzyna, Peter A ^a   Gianella, Anita ^a,b   Skajaa, Torjus ^a,c   Knudsen, Gitte ^a   Deddens, Lisette H ^a,d   Cormode, David P ^a   Fayad, Zahi A ^a   Mulder, Willem J M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENCAPSULATED DRUGS; IMAGING PROBE; IMAGING PROPERTIES; IN-VIVO; INORGANIC NANOCRYSTALS; MULTIMODALITY IMAGING; NANO PARTICULATES; NANO-MATERIALS; PATHOLOGICAL PROCESS; PROTEINS/PEPTIDES; SUB-CELLULAR; THERAPEUTIC POTENTIALS; THERMAL ABLATION; WHOLE BODY;

ABLATION; IMAGING TECHNIQUES; NANOPROBES; NUCLEIC ACIDS;

PROBES;

BIOMATERIAL; DOXORUBICIN; INORGANIC COMPOUND; LIPID; NANOCRYSTAL; NANOPARTICLE; NUCLEIC ACID; PEPTIDE; POLYMER; PROTEIN;

COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; HUMAN; IMAGING; IN VIVO STUDY; ISOTOPE LABELING; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICULATE MATTER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERMAL EXPOSURE;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; MOLECULAR PROBES; NANOPARTICLES; TEMPERATURE;

EID: 77953676865     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.72     Document Type: Review

References (65)

1. Cormode DP, Skajaa T, Fayad ZA, Mulder WJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol 2009, 29:992-1000.
2. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
3. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
4. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat.Biotechnol. 2006, 24:1211-1217.
5. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
6. Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007, 24:1-16.
7. Ansari MJ, Kohli K, Dixit N. Microemulsions as potential drug delivery systems: a review. PDA J Pharm Sci Technol 2008, 62:66-79.
8. Bagwe RP, Kanicky JR, Palla BJ, Patanjali PK, Shah DO. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001, 18:77-140.
9. Vucic E, Sanders HM, Arena F, Terreno E, Aime S, et al. Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. J Am Chem Soc 2009, 131:406-407.
10. Cormode DP, Mulder WJM, Fisher EA, Fayad ZA. Modified lipoproteins as contrast agents for molecular imaging. Future Lipidol 2007, 2:587-590.
11. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007, 18:241-268.
12. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
13. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17:484-499.
14. Mulder WJ, Strijkers GJ, van Tilborg GA, Cormode DP, Fayad ZA, et al. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009, 42:904-914.
15. Silva GA. Nanomedicine: seeing the benefits of ceria. Nat Nanotechnol 2006, 4:92-94.
16. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759-1782.
17. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006, 19:142-164.
18. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007, 13:636-641.
19. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005, 16:89-92.
20. Mulder WJ, Cormode DP, Hak S, Lobatto ME, Silvera S, et al. Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med 2008, (suppl 2):S103-S111.
21. Bailon P, Won CY. PEG-modified biopharmaceuticals. Expert Opin Drug Deliv 2009, 6:1-16.
22. McCarthy JR, Kelly KA, Sun EY, Weissleder R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2007, 2:153-167.
23. Schiffelers RM, de Wolf HK, van RI, Storm G. Synthetic delivery systems for intravenous administration of nucleic acids. Nanomed 2007, 2:169-181.
24. Hilger I, Hiergeist R, Hergt R, Winnefeld K, Schubert H, et al. Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol 2002, 37:580-586.
25. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004, 209:171-176.
26. Mitra A, Nan A, Line BR, Ghandehari H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des 2006, 12:4729-4749.
27. Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 2007, 7:291-305.
28. Woods M, Woessner DE, Sherry AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006, 35:500-511.
29. Bulte JW. Hot spot MRI emerges from the background. Nat Biotechnol 2005, 23:945-946.
30. Yu SB,Watson AD. Metal-based X-ray contrast media. Chem Rev 1999, 99:2353-2378.
31. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 2005, 23:313-320.
32. Huber MM, Staubli AB, Kustedjo K, Gray MH, Shih J, et al. Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem 1998, 9:242-249.
33. Mulder WJ, Griffioen AW, Strijkers GJ, Cormode DP, Nicolay K, et al. Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomed 2007, 2:307-324.
34. Frullano L, Meade TJ. Multimodal MRI contrast agents. J Biol Inorg Chem 2007, 12:939-949.
35. Schipper ML, Cheng Z, Lee SW, Bentolila LA, Iyer G, et al. microPET-based biodistribution of quantum dots in living mice. J Nucl Med 2007, 48:1511-1518.
36. Mulder WJ, Koole R, Brandwijk RJ, Storm G, Chin PT, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006, 6:1-6.
37. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, et al. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 2009, 12:17-24.
38. Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, et al. In vivomagnetic resonance imaging of transgene expression. Nat Med 2000, 6:351-355.
39. Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med 2005, 54:718-724.
40. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114:1504-1511.
41. Devaraj NK, Keliher EJ, Thurber GM, Nahrendorf M, Weissleder R. 18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem 2009, 20:397-401.
42. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117:379-387.
43. Koole R, van Schooneveld MM, Hilhorst J, Castermans K, Cormode DP, et al. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform formultimodality imaging. Bioconjug Chem 2008, 19:2471-2479.
44. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 2008, 8:2517-2525.
45. Kim J, Kim HS, Lee N, Kim T, Kim H, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl 2008, 47:8438-8441.
46. Rieter WJ, Kim JS, Taylor KM, An H, Lin W, et al. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed Engl 2007, 46:3680-3682.
47. Zhang Y, Wang SN, Ma S, Guan JJ, Li D, et al. Self-assembly multifunctional nanocomposites with Fe3O4 magnetic core and CdSe/ZnS quantum dots shell. J Biomed Mater Res A 2008, 85:840-846.
48. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008, 8:3715-3723.
49. Lanza GM, Winter P, Caruthers S, Schmeider A, Crowder K, et al. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Curr Pharm Biotechnol 2004, 5:495-507.
50. Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:2103-2109.
51. Schmieder AH, Caruthers SD, Zhang H, Williams TA, Robertson JD, et al. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDAMB-435 xenograft mouse model. FASEB J 2008, 22:4179-4189.
52. Kim J, Lee JE, Lee SH, Yu JH, Lee JH, et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater 2008, 20:478.
53. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006, 6:2427-2430.
54. Park JH, von Maltzahn G, Ruoslahti E, Bhatia SN, Sailor MJ. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl 2008, 47:7284-7288.
55. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, et al.Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
56. Lai CW, Wang YH, Lai CH, Yang MJ, Chen CY, et al. Iridium-complex- functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008, 4:218-224.
57. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007, 13:372-377.
58. Qi L, Gao X. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. ACS Nano 2008, 2:1403-1410.
59. Lee JS, Green JJ, Love KT, Sunshine J, Langer R, et al. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9:2402-2406.
60. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME, et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 2007, 104:15549-15554.
61. Lee JH, Lee K, Moon SH, Lee Y, Park TG, et al. All-in-one target-cell-specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl 2009, 48:4174-4179.
62. Lim YT, Cho MY, Kim JK, Hwangbo S, Chung BH. Plasmonicmagnetic nanostructure for bimodal imaging and photonic-based therapy of cancer cells. Chembiochem 2007, 8:2204-2209.
63. Larson TA, Bankson J, Aaron J, Sokolov K. Hybrid plasmonic magnetic nanoparticles as molecular specific agents for MRI/optical imaging and photothermal therapy of cancer cells. Nanotechnology 2007, 18:325101/1-325101/8.
64. Wang C, Chen J, Talavage T, Irudayaraj J. Gold nanorod/Fe3O4 nanoparticle "nano-pearl-necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. Angew Chem Int Ed Engl 2009, 48:2759-2763.
65. Lim YT, Cho MY, Choi BS, Lee JM, Chung BH. Paramagnetic gold nanostructures for dual modal bioimaging and phototherapy of cancer cells. Chem Commun (Camb) 2008, 28:4930-4932.